AIM logo
Alcohol in
Moderation
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • Cognitive decline
  • Parkinsons' disease& alcohol
  • Arthritis& alcohol
  • Stroke
  • Women& alcohol
    • Breast cancer
    • Pregnancy
Choose a Topic
January 2025
Diabetes

Association between alcohol consumption and risk of type 2 diabetes

Heavy alcohol consumption is a known risk factor for type 2 diabetes (T2D); However, the moderating effect of fasting plasma glucose levels remains unclear. A study explored the relationship between alcohol intake and T2D risk across fasting plasma glucose strata in a Japanese cohort.
Data from 15,453 participants in the NAGALA cohort were analysed over 5 years. Baseline assessments included alcohol consumption and fasting plasma glucose, categorising individuals into elevated fasting plasma glucose (100-125 mg/dL) and normal fasting plasma glucose (< 100 mg/dL). Alcohol intake levels and T2D risk were assessed, stratified by fasting plasma glucose. Among elevated fasting plasma glucose individuals, heavy drinkers (Men > 280 g/week, Women > 140 g/week) had an 88% increased T2D risk (HR 1.88, 95% CI 1.24-2.84). Conversely, in normal fasting plasma glucose, heavy alcohol intake did not significantly affect T2D risk (HR 1.10, 95% CI 0.48-2.53). Men with elevated fasting plasma glucose and heavy alcohol intake had an HR of 1.83 (95% CI 1.08-3.08), supported by propensity score matching (HR 1.94, 95% CI 1.13-3.34). No significant relationships were found in normal fasting plasma glucose. Heavy alcohol consumption significantly raised T2D risk in Japanese men with elevated fasting plasma glucose but not in women or those with normal fasting plasma glucose. Further studies are warranted for validation and gender-specific insights.
Source: Huang, YZ., Luo, F., Ran, X. et al. Association between alcohol consumption and risk of type 2 diabetes in Japan: a population-base longitudinal cohort study. Science Report, 15:630, 2025

doi.org/10.1038/s41598-024-84597-5
Drinking & You logo
Drinking & You
A global portal providing advice about responsible alcohol consumption, individual country government guidelines and your health.
Go to website
International Scientific Forum on Alcohol Research logo
International Scientific Forum on Alcohol Research
The International Scientific Forum on Alcohol Research (ISFAR) is a group of 45 specialist Professors and Medics who produce balanced and well researched analysis of emerging research papers alcohol and health.
Go to website

To receive notification of updates to the website, please subscribe here

Name(Required)

Topics

Harmful consumption

& alcohol

Healthy lifestyle

& alcohol

Genetics

& alcohol

Depression

& alcohol

Mental health

& alcohol

All-cause mortality

& alcohol

Cancer

& alcohol

Diabetes

& alcohol

Heart

& alcohol

Antioxidants

& alcohol

Bone mineral density

& alcohol

The brain

& alcohol

General health

& alcohol

Gut health

& alcohol

J-shaped curve

& alcohol

The kidneys

& alcohol

The liver

& alcohol

Mediterranean diet

& alcohol

Metabolic syndrome/weight

& alcohol

Moderate drinking

Old age

& alcohol

Parkinsons' disease

& alcohol

Arthritis

& alcohol

Stroke

& alcohol

Women

& alcohol

Latest articles

Reevaluating the alcohol–cancer link: Long-term cancer mortality outcomes in the REGARDS Study

Zero tolerance for 0%? How should clinicians and other practitioners respond to the use of alcohol-free and low-alcohol products in higher risk groups

Alcohol consumption and molecular subtypes of colorectal cancer: pooled observational and Mendelian randomization analyses

Alcohol consumption and the incidence of hyperuricemia in Japanese men and women

Alcohol-attributable cancer risk and burden estimates for Australia’s updated alcohol consumption guidelines

Aim Digest

September 2026

June 2026

May 2026

April 2026

February 2026

© Alcohol In Moderation, 2026.
Web design by Rubber Duckers
Close menu
  • Home
  • Articles
  • Aim Digest
  • About AIM
  • AIM Council
Subscribe
Log in
Close menu
  • All articles
  • All critiques
  • All-cause mortality& alcohol
  • Cancer& alcohol
    • ← Back
    • Breast cancer
    • Colorectal cancers
    • Head and neck cancers
    • Lung cancer
    • Prostate cancer
  • Diabetes& alcohol
  • Heart& alcohol
    • ← Back
    • Arrhythmia
    • Cardiovascular disease
    • Coronary heart disease
    • Cholesterol
    • Heart attack
    • Heart failure
    • Hypertension
  • Antioxidants& alcohol
  • Bone mineral density& alcohol
  • The brain& alcohol
    • ← Back
    • Cognitive decline
  • General health& alcohol
  • J-shaped curve& alcohol
  • The kidneys& alcohol
  • The liver& alcohol
  • Mediterranean diet& alcohol
  • Moderate drinking
  • Old age& alcohol
    • ← Back
    • Cognitive decline
  • Parkinsons' disease& alcohol
  • Arthritis& alcohol
  • Stroke
  • Women& alcohol
    • ← Back
    • Breast cancer
    • Pregnancy